Form 4: Vertex Pharmaceuticals Director Diana McKenzie Reports Changes in Beneficial Ownership
SEC Form 4 Filing
Director Diana McKenzie reports acquisition and disposition of Vertex Pharmaceuticals common stock and deferred stock units on May 1, 2024.
Summary
- On May 1, 2024, Diana McKenzie, a director of Vertex Pharmaceuticals, reported changes in her beneficial ownership of the company's securities.
- She acquired 1,001 shares of common stock through a restricted stock unit award that vests on the first anniversary of the grant date.
- She also disposed of 1,168 shares of common stock in exchange for an equal number of deferred stock units under the company's deferred compensation plan.
- Following these transactions, Ms. McKenzie directly owns 2,436 shares of common stock and indirectly owns 207 shares held in trust.
- She also holds 5,990.483 deferred stock units, each representing one share of common stock, payable upon termination of board service, change of control, disability, or death.
Sentiment
Score: 6
Explanation: The document is a routine regulatory filing detailing stock transactions by a company director. It doesn't inherently convey positive or negative sentiment, but rather provides factual information. The sentiment is neutral to slightly positive due to the director's continued investment in the company.
Positives
- The acquisition of 1,001 shares through a restricted stock unit award indicates continued alignment with the company's long-term success.
Future Outlook
The deferred stock units will be paid out in common stock upon the earliest occurrence of termination of Ms. McKenzie's service on the board, a change of control of the company, or Ms. McKenzie's disability or death.
Industry Context
Form 4 filings are standard disclosures required by the SEC to provide transparency into the transactions of company insiders, allowing investors to track potential shifts in ownership and sentiment.
Stakeholder Impact
- The transactions may have a minor impact on shareholders by slightly altering the ownership structure.
Key Dates
| Date | Description |
|---|---|
| 05/01/2023 | Date of restricted stock units granted to Ms. McKenzie that vested. |
| 05/01/2024 | Date of transactions: acquisition of common stock and disposition of common stock for deferred stock units. |
| 05/03/2024 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.